Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine

Tumour cell metabolism is very different from normal cell metabolism; cancer cells re-programme the metabolic pathways that occur in normal cells in such a manner that it optimizes their proliferation, growth and survival. Although this metabolic re-programming obviously operates to the advantage of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhutia, Yangzom D., Babu, Ellappan, Ganapathy, Vadivel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2016
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888454/
https://www.ncbi.nlm.nih.gov/pubmed/27234586
http://dx.doi.org/10.1042/BCJ20160068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888454/
https://www.ncbi.nlm.nih.gov/pubmed/27234586
http://dx.doi.org/10.1042/BCJ20160068

Ejemplares similares